Study Finds No Increased Long-Term Risk of Rheumatoid Arthritis in Adults with Autism Spectrum Disorder
Research Overview
A recent large-scale study investigated whether adults diagnosed with autism spectrum disorder (ASD) face a higher long-term risk of developing rheumatoid arthritis (RA), an autoimmune condition affecting joints. The study analyzed data from Swedish national registers, following individuals with ASD and matched controls over several decades to assess the incidence of RA.
Key Findings
The study included 46,164 individuals diagnosed with ASD between 1987 and 2017, matched by sex and birth year to over 4.6 million controls. Participants were monitored from age 18 until RA diagnosis, death, emigration, or the end of the follow-up period, allowing up to 30 years of observation.
Results showed that RA diagnosis rates were very similar between the ASD group (0.13%) and the control group (0.12%). Statistical analysis using Cox proportional hazards models indicated no significant increase in RA risk among those with ASD. The overall hazard ratio (HR) was 1.06 with a 95% confidence interval (CI) of 0.82 to 1.37, suggesting no meaningful difference. When examining RA subtypes, the HR was 1.00 (95% CI 0.67–1.48) for seropositive RA and 1.12 (95% CI 0.79–1.57) for seronegative RA.
Additional Analyses and Context
The researchers conducted further analyses adjusting for parental history of autoimmune and psychiatric disorders, as well as socioeconomic factors. These adjustments did not materially change the findings, with an adjusted HR of 1.34 (95% CI 0.97–1.84), still indicating no clear increased risk. Sensitivity analyses using alternative statistical models and RA subtype definitions supported the robustness of these conclusions.
Despite previous suggestions of immune system differences and shared genetic factors between ASD and autoimmune diseases, this comprehensive population-based study did not find evidence that ASD is linked to a higher risk of RA in adulthood.
Implications for Families and Clinicians
These findings contribute to understanding the health profile of autistic adults, particularly regarding autoimmune comorbidities. While immune dysfunction has been hypothesized in ASD, this study suggests that routine clinical monitoring for RA specifically may not need to be heightened solely based on an ASD diagnosis.
Limitations and Considerations
As with all observational studies, causation cannot be established, and the results pertain to the population studied—primarily individuals in Sweden. The follow-up period extends into adulthood but may not capture very late-onset RA cases. Additionally, the study focuses on RA and does not address other autoimmune conditions that might have different associations with ASD.
Overall, this research provides evidence that ASD does not appear to increase the risk of developing rheumatoid arthritis during adulthood.
For more detailed information, the original study can be accessed here.
Download the images in this article
